Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
about
Safety of aerosolized amphotericin B.Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.Variation in antifungal prophylaxis strategies in lung transplantation.Amphotericin B in lung transplant recipients.A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis.Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
P2860
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@en
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@nl
type
label
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@en
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@nl
prefLabel
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@en
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@nl
P2093
P2860
P356
P1476
Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
@en
P2093
Evan H Kwong
Guy Fradet
Kishor M Wasan
Mary H H Ensom
Nilufar Partovi
Robert D Levy
Shawn M Cassidy
P2860
P356
10.1345/APH.1A015
P407
P577
2002-01-01T00:00:00Z